ADCs in the Treatment of Breast Cancer and Gastric Cancer and Managing AEs Associated with ADCs - Episode 10

Patient Profile 3: A Patient with HER2+ Gastric Cancer Treated With T-DXd–who Develops Neutropenia

, , ,

Centering discussion on a patient profile of HER2+ gastric cancer, experts in oncology discuss the occurrence of neutropenia with trastuzumab deruxtecan therapy.

EP. 1: Patient Profile 1: A Patient With HER2+ Metastatic BC Treated With T-DXd who Develops ILD
EP. 2: Adverse Event Management With T-DXd in Patients With Breast or Gastric Cancers
EP. 3: Management of Interstitial Lung Disease Related to T-DXd in Breast or Gastric Cancers
EP. 4: Selecting Appropriate Patients with MBC for T-DXd and Counseling for AEs
EP. 5: Sequencing Therapy in MBC in Second Line and Beyond
EP. 6: Patient Profile 2: A Patient With HER2+ MBC Treated With T-DM1 who Develops Neuropathy
EP. 7: Role of T-DM1 in Patients With HER2+ Breast and Gastric Cancers
EP. 8: Managing AEs With Trastuzumab Emtansine in Breast and Gastric Cancers
EP. 9: A Brief Review of Ongoing Clinical Trials of ADCs in Breast Cancer
Now Viewing
EP. 10: Patient Profile 3: A Patient with HER2+ Gastric Cancer Treated With T-DXd–who Develops Neutropenia
EP. 11: First- and Second-Line Treatment Options for HER2+ Gastric Cancer
EP. 12: T-DXd in HER2+ Gastric Cancer: Managing Neutropenia and Other AEs
EP. 13: Ongoing Clinical Trials With T-DXd in HER2+ Gastric Cancer
EP. 14: Patient Profile 4: A Patient with HER2+ Gastric Cancer Treated With T-DXd Who Develops Diarrhea